Diversified Trust Co Has $2.75 Million Position in Cardinal Health, Inc. (NYSE:CAH)

Diversified Trust Co decreased its holdings in Cardinal Health, Inc. (NYSE:CAHFree Report) by 4.9% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 23,207 shares of the company’s stock after selling 1,196 shares during the quarter. Diversified Trust Co’s holdings in Cardinal Health were worth $2,745,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Eastern Bank acquired a new position in Cardinal Health in the third quarter worth about $25,000. Frazier Financial Advisors LLC grew its stake in shares of Cardinal Health by 69.8% in the 3rd quarter. Frazier Financial Advisors LLC now owns 253 shares of the company’s stock valued at $28,000 after purchasing an additional 104 shares during the period. Ashton Thomas Private Wealth LLC acquired a new position in shares of Cardinal Health in the 2nd quarter worth approximately $29,000. Hara Capital LLC acquired a new stake in Cardinal Health in the 3rd quarter valued at $31,000. Finally, AM Squared Ltd bought a new stake in Cardinal Health in the third quarter valued at $33,000. 87.17% of the stock is owned by institutional investors.

Cardinal Health Trading Up 1.2 %

Shares of NYSE CAH opened at $121.11 on Wednesday. Cardinal Health, Inc. has a 1 year low of $93.17 and a 1 year high of $126.23. The firm’s 50-day moving average is $119.20 and its 200-day moving average is $110.68. The firm has a market capitalization of $29.31 billion, a PE ratio of 23.56, a price-to-earnings-growth ratio of 1.47 and a beta of 0.63.

Cardinal Health (NYSE:CAHGet Free Report) last released its earnings results on Friday, November 1st. The company reported $1.88 EPS for the quarter, topping analysts’ consensus estimates of $1.62 by $0.26. The firm had revenue of $52.28 billion during the quarter, compared to analyst estimates of $50.90 billion. Cardinal Health had a net margin of 0.56% and a negative return on equity of 56.56%. The business’s quarterly revenue was down 4.3% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.73 EPS. As a group, equities research analysts anticipate that Cardinal Health, Inc. will post 7.82 earnings per share for the current fiscal year.

Cardinal Health Cuts Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, January 15th. Shareholders of record on Thursday, January 2nd will be paid a $0.5056 dividend. This represents a $2.02 annualized dividend and a yield of 1.67%. The ex-dividend date of this dividend is Thursday, January 2nd. Cardinal Health’s payout ratio is 39.30%.

Wall Street Analyst Weigh In

CAH has been the topic of several recent analyst reports. UBS Group boosted their target price on shares of Cardinal Health from $134.00 to $139.00 and gave the company a “buy” rating in a research note on Monday, November 4th. Evercore ISI upgraded shares of Cardinal Health from an “in-line” rating to an “outperform” rating and set a $140.00 price target on the stock in a research report on Tuesday. Argus lifted their target price on shares of Cardinal Health from $115.00 to $125.00 and gave the company a “buy” rating in a research note on Wednesday, September 11th. Deutsche Bank Aktiengesellschaft increased their price target on Cardinal Health from $119.00 to $124.00 and gave the stock a “hold” rating in a research report on Monday, November 4th. Finally, Wells Fargo & Company upgraded Cardinal Health from an “underweight” rating to an “equal weight” rating and lifted their price objective for the company from $101.00 to $127.00 in a research report on Friday, December 13th. Four investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $130.77.

Get Our Latest Stock Analysis on CAH

About Cardinal Health

(Free Report)

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

Recommended Stories

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAHFree Report).

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.